Home / News

Net Profit Rose 197.83% to CNY 2.016 Billion! Wantai Biopharm Released 2021 Full-year Results

2022/2/15 18:38:43 Views£º497

Description of operating performance and financial status

 

£¨1£©operating conditions, financial conditions and main factors affecting operating performance during the reporting period

 

At the end of the reporting period, the total assets of the company were CNY 7.047 billion, an increase of 101.13% over the beginning of the period; The owner's equity attributable to shareholders of listed companies was CNY 4.461 billion, an increase of 74.69% over the beginning of the period. The main factors affecting the business performance are that the company's bivalent cervical cancer vaccine continues to maintain prosperous production and sales, and the revenue and profit increase at a high speed; Due to COVID-19 epidemic has not been effectively controlled, the demand for overseas detection has increased significantly, and the COVID-19 material sales and overseas reagent reagent export revenue has achieved rapid growth.

 

£¨2£©reasons for increase and decrease of main financial data

 

1. The increase in operating income was mainly due to the increase in the income of bivalent cervical cancer vaccines, reagents and active raw materials.

 

2. The increase in operating profit, total profit, net profit attributable to shareholders of listed companies and net profit attributable to shareholders of listed companies after deducting non recurring profits and losses is mainly due to the increase in net profit brought by the increase in the income of bivalent cervical cancer vaccine, reagent and active raw materials.

 

3. The increase in basic earnings per share was mainly due to the increase in net profit brought by the increase in the income of bivalent cervical cancer vaccines, reagents and active raw materials.

 

4. The increase of weighted net profit rate is mainly due to the large increase of weighted net profit rate.

 

5. The increase of total assets was mainly due to the increase of accounts receivable, monetary funds and projects under construction brought by the sales and collection of bivalent cervical cancer vaccine.

 

6. The increase in owner's equity attributable to shareholders of listed companies was mainly due to the significant increase in sales revenue, resulting in a significant increase in net profit.

 

7. The increase in share capital is due to the company's distribution of stock dividends to all shareholders with undistributed profits in 2021.

 

CACLP 2022£¨March 27th-29th,2022 | Nanchang,China£©

Booth number:A2-2909

CAIVD WeChat
Subscription Account
CAIVD WeChat
Channels

China Association of In-vitro Diagnostics

Part of the information in our website is from the internet.

If by any chance it violates your rights, please contact us.